| Euronext Paris: BIM
bioMérieux SA provides clinical diagnosis. Its business activities include In Vitro Diagnostics, Clinical Diagnostics and Industrial Microbiological Control. The In Vitro Diagnostics provides diagnostics for medical and industrial applications. It offers in vitro diagnosis, which serves as the basis for medical diagnosis, patient treatment and therapy monitoring. It contributes to the field of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory infection and pathologies such as cancer and cardiovascular diseases. bioMérieux provides diagnostic solutions, which include reagents, instruments and software. The company performs clinical diagnosis through three technologies, bacteriology, immunoassays and molecular biology. It operates through the following segment: In Vitro Diagnostics. bioMerieux was founded in 1963 and is headquartered in Marcy l'Etoile, France.